Sunshine Biopharma (SBFMW) Return on Invested Capital (2022 - 2025)
Historic Return on Invested Capital for Sunshine Biopharma (SBFMW) over the last 4 years, with Q3 2025 value amounting to 0.24%.
- Sunshine Biopharma's Return on Invested Capital fell 300.0% to 0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.25% for FY2024, which is 0.0% changed from last year.
- According to the latest figures from Q3 2025, Sunshine Biopharma's Return on Invested Capital is 0.24%, which was down 300.0% from 0.26% recorded in Q2 2025.
- Sunshine Biopharma's 5-year Return on Invested Capital high stood at 0.19% for Q2 2024, and its period low was 1.36% during Q1 2023.
- Its 4-year average for Return on Invested Capital is 0.55%, with a median of 0.24% in 2023.
- In the last 5 years, Sunshine Biopharma's Return on Invested Capital skyrocketed by 11500bps in 2024 and then tumbled by -700bps in 2025.
- Quarter analysis of 4 years shows Sunshine Biopharma's Return on Invested Capital stood at 0.88% in 2022, then soared by 72bps to 0.24% in 2023, then rose by 7bps to 0.23% in 2024, then dropped by -5bps to 0.24% in 2025.
- Its last three reported values are 0.24% in Q3 2025, 0.26% for Q2 2025, and 0.23% during Q1 2025.